From GlobeNewswire: 2025-03-21 10:00:00

The Clinical Diagnostics Market was valued at USD 79.06 billion in 2023, projected to reach USD 127.80 billion by 2032 with a CAGR of 5.5%. Technological advancements and rising chronic diseases are key drivers. Infectious Disease Testing led in 2023, while the CBC segment is expected to grow rapidly. Reagents dominated the market, with instruments set for strong growth. Hospital labs led in 2023, with POCT segment expected to grow rapidly. North America led in 2023, with Asia-Pacific expected to see the highest growth. Roche received CE mark approval for cobas Mass Spec solution in December 2024. Amprion’s SAAmplify-ɑSYN assay wins the 2024 BioTech Breakthrough Award for ‘Clinical Diagnostics Solution of the Year,’ aiding in diagnosing neurodegenerative conditions. Deciphex receives €31 million in funding for AI-powered diagnostic platforms to address the global shortage of pathologists. The global burden of chronic diseases drives demand for clinical diagnostics, with a surge in diagnostic tests, especially for infectious diseases and routine blood tests. The market for diagnostic devices is growing steadily, with increased adoption of automated solutions and rising healthcare expenditures on diagnostics globally.



Read more at GlobeNewswire: Global Clinical Diagnostics Market Size to Hit USD 127.80